{"id":51435,"url":"https://lda.senate.gov/api/v1/clients/51435/?format=json","client_id":51435,"name":"AMGEN","general_description":"Biopharmaceutical manufacturer","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-06","registrant":{"id":401106477,"url":"https://lda.senate.gov/api/v1/registrants/401106477/?format=json","house_registrant_id":45531,"name":"HAGGERTY POLICY SOLUTIONS","description":null,"address_1":"121 S Hudson St","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22204","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEANNE HAGGERTY","contact_telephone":"+1 202-860-6320","dt_updated":"2025-01-26T11:43:07.297671-05:00"}}